These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22167324)

  • 1. Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy.
    Hernández C; Simó R
    Endocrine; 2012 Apr; 41(2):220-6. PubMed ID: 22167324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin in diabetic retinopathy.
    Reid G; Lois N
    Vision Res; 2017 Oct; 139():237-242. PubMed ID: 28652140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin exerts a neuroprotective function against glutamate neurotoxicity in experimental diabetic retina.
    Gu L; Xu H; Wang F; Xu G; Sinha D; Wang J; Xu JY; Tian H; Gao F; Li W; Lu L; Zhang J; Xu GT
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(12):8208-22. PubMed ID: 25335981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamylated erythropoietin mediates retinal neuroprotection in streptozotocin-induced early-stage diabetic rats.
    Liu X; Zhu B; Zou H; Hu D; Gu Q; Liu K; Xu X
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1263-72. PubMed ID: 25725621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Adenosinergic System in Diabetic Retinopathy.
    Vindeirinho J; Santiago AR; Cavadas C; Ambrósio AF; Santos PF
    J Diabetes Res; 2016; 2016():4270301. PubMed ID: 27034960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic functions of erythropoietin.
    Sasaki R
    Intern Med; 2003 Feb; 42(2):142-9. PubMed ID: 12636232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The non-haematopoietic biological effects of erythropoietin.
    Arcasoy MO
    Br J Haematol; 2008 Apr; 141(1):14-31. PubMed ID: 18324962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin in the brain: can the promise to protect be fulfilled?
    Maiese K; Li F; Chong ZZ
    Trends Pharmacol Sci; 2004 Nov; 25(11):577-83. PubMed ID: 15491780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2.
    Kilic U; Kilic E; Soliz J; Bassetti CI; Gassmann M; Hermann DM
    FASEB J; 2005 Feb; 19(2):249-51. PubMed ID: 15556972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
    N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non erythropoietic effects of Erythropoietin].
    Guglielmo C; Cantarelli C; Angeletti A; Todeschini P; Cravedi P
    G Ital Nefrol; 2019 Sep; 36(5):. PubMed ID: 31580542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina.
    Wang Q; Pfister F; Dorn-Beineke A; vom Hagen F; Lin J; Feng Y; Hammes HP
    Diabetologia; 2010 Jun; 53(6):1227-38. PubMed ID: 20339831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of erythropoietin in the brain.
    Noguchi CT; Asavaritikrai P; Teng R; Jia Y
    Crit Rev Oncol Hematol; 2007 Nov; 64(2):159-71. PubMed ID: 17482474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPO protects Müller cell under high glucose state through BDNF/TrkB pathway.
    Wang P; Xia F
    Int J Clin Exp Pathol; 2015; 8(7):8083-90. PubMed ID: 26339375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin therapy for early diabetic retinopathy through its protective effects on retinal pericytes.
    Wang ZY; Zhao KK; Zhao PQ
    Med Hypotheses; 2011 Feb; 76(2):266-8. PubMed ID: 21051154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with suberythropoietic Epo is vaso- and neuroprotective in experimental diabetic retinopathy.
    Wang Q; Gorbey S; Pfister F; Höger S; Dorn-Beineke A; Krügel K; Berrone E; Wu L; Korff T; Lin J; Busch S; Reichenbach A; Feng Y; Hammes HP
    Cell Physiol Biochem; 2011; 27(6):769-82. PubMed ID: 21691094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy].
    Watanabe D
    Nippon Ganka Gakkai Zasshi; 2007 Nov; 111(11):892-8. PubMed ID: 18051819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular biology of erythropoietin.
    Lacombe C; Mayeux P
    Nephrol Dial Transplant; 1999; 14 Suppl 2():22-8. PubMed ID: 10334664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the erythropoietin-induced erythroid differentiation by granulocyte-macrophage colony-stimulating factor in the human UT-7 cell line is not due to a negative regulation of the erythropoietin receptor.
    Hermine O; Dubart A; Porteux F; Mayeux P; Titeux M; Dumenil D; Vainchenker W
    Blood; 1996 Mar; 87(5):1746-53. PubMed ID: 8634420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin: multiple physiological functions and regulation of biosynthesis.
    Sasaki R; Masuda S; Nagao M
    Biosci Biotechnol Biochem; 2000 Sep; 64(9):1775-93. PubMed ID: 11055378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.